Skip to main content
Premium Trial:

Request an Annual Quote

Strategic Diagnostics' Q3 Profit Erased on Increased Tax Expense

NEW YORK (GenomeWeb News) — Strategic Diagnostics said Wednesday that a $100,000 tax adjustment has erased its entire third-quarter profit.
 
The company’s original earnings report for the three months ended Sept. 30, disclosed Nov. 1, showed a $100,000 profit, which was a decline from the $332,000 it earned during the comparable period one year earlier.
  
The $100,000 profit included a tax expense of $175,000, which included an adjustment designed to reconcile a tax provision for the year ended Dec. 31, 2006, with the actual filing of the 2006 tax return. When Strategic Diagnostics issued its earnings report Nov. 1 it said that "a review of this additional tax expense was continuing." 
 
On Wednesday, the company said it has completed the review and raised its tax expense for the period to $275,000, which in turn erased its profit for the third quarter.
The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.